Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 7, 2014, Pages 2698-2703

  Ahn, G One ^a,b   Seita, Jun ^c   Hong, Beom Ju ^a   Kim, Young Eun ^a   Bok, Seoyeon ^a   Lee, Chan Ju ^a   Kim, Kwang Soon ^a   Lee, Jerry C ^d   Leeper, Nicholas J ^d   Cooke, John P ^d   Kim, Hak Jae ^e   Kim, Il Han ^e   Weissman, Irving L ^c   Brown, J Martin ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Department of Radiation Oncology ^*  (United States)

^c Institute for Stem Cell Biology and Regenerative Medicine   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BONE MARROW; BONE MARROW CELL; CONTROLLED STUDY; ERYTHEMA; LIMB ISCHEMIA; MONOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CALGRANULIN A; COLLAGEN; CROSSES, GENETIC; DNA PRIMERS; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HINDLIMB; HYPOXIA-INDUCIBLE FACTOR 1; ISCHEMIA; LAMININ; MICE; MICE, TRANSGENIC; MYELOID CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; PROTEOGLYCANS; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894299576     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320243111     Document Type: Article

References (37)

1. Lamalice L, Le Boeuf F, Huot J (2007) Endothelial cell migration during angiogenesis. Circ Res 100(6):782-794.
2. Granata F, et al. (2010) Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2. J Immunol 184(9):5232-5241.
3. Medina RJ, et al. (2011) Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8. Mol Med 17(9-10):1045-1055.
4. Kujawski M, et al. (2008) Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice. J Clin Invest 118(10):3367-3377.
5. Shojaei F, Zhong C, Wu X, Yu L, Ferrara N (2008) Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18(8):372-378.
6. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721-732.
7. Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK (2006) A novel role of hypoxiainducible factor in cobalt chloride-and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177(10):7211-7224.
8. Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, Melillo G (2006) Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107(7):2705-2712.
9. Haase VH (2010) Hypoxic regulation of erythropoiesis and iron metabolism. Am J Physiol Renal Physiol 299(1):F1-F13.
10. Cramer T, et al. (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112(5):645-657.
11. Imtiyaz HZ, et al. (2010) Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120(8): 2699-2714.
12. Lagasse E, Weissman IL (1992) Mouse MRP8 and MRP14, two intracellular calciumbinding proteins associated with the development of the myeloid lineage. Blood 79(8):1907-1915.
13. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8(4): 265-277.
14. Purhonen S, et al. (2008) Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 105(18):6620-6625.
15. Shibuya M (2006) Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol 39(5):469-478.
16. Haase VH (2006) Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 291(2):F271-F281.
17. Chau N-M, et al. (2005) Identification of novel small molecule inhibitors of hypoxiainducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res 65(11):4918-4928.
18. Jaiswal S, et al. (2003) Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc Natl Acad Sci USA 100(17):10002-10007.
19. Yuan Y, et al. (2001) AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci USA 98(18):10398-10403.
20. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J (2009) The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 86(3):557-566.
21. Hsu K, et al. (2005) Regulation of S100A8 by glucocorticoids. J Immunol 174(4): 2318-2326.
22. Wondimu A, et al. (2012) Loss of Arnt (Hif1ß) in mouse epidermis triggers dermal angiogenesis, blood vessel dilation and clotting defects. Lab Invest 92(1):110-124.
23. Grebhardt S, Veltkamp C, Ströbel P, Mayer D (2012) Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. Int J Cancer 131(12):2785-2794.
24. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA (2003) Proinflammatory activities of S100: Proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 170(6):3233-3242.
25. Viemann D, et al. (2005) Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 105(7):2955-2962.
26. Frosch M, et al. (2000) Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 43(3):628-637.
27. Robinson MJ, Tessier P, Poulsom R, Hogg N (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277(5):3658-3665.
28. Li C, et al. (2012) Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: Bridges among inflammation, angiogenesis, and tumorigenesis? Mediators Inflamm 2012:248574.
29. Viemann D, et al. (2007) MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and-independent cell death program. Blood 109(6):2453-2460.
30. Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160(3):1427-1435.
31. Pouliot P, Plante I, Raquil M-A, Tessier PA, Olivier M (2008) Myeloid-related proteins rapidly modulate macrophage nitric oxide production during innate immune response. J Immunol 181(5):3595-3601.
32. Weidemann A, Johnson RS (2008) Biology of HIF-1alpha. Cell Death Differ 15(4): 621-627.
33. White JR, et al. (2004) Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 83(1):1-8.
34. Fang HY, et al. (2009) Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114(4):844-859.
35. Mohler ER, 3rd, et al. (2003) Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: Safety results from a phase I trial. Vasc Med 8(1):9-13.
36. Lawall H, Bramlage P, Amann B (2010) Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 103(4):696-709.
37. Passegué E, Wagner EF, Weissman IL (2004) JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119(3):431-443.